Hemab Therapeutics Holdings, Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Hemab Therapeutics Holdings, Inc. (COAG) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 26.50 million shares as of 2026-05-04, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2026-08-11
- 2026-05-04: Stock Issued During Period, Shares, Conversion of Convertible Securities 26.50M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2026-05-04 | 26.50M shares 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |